Form 4 · Statement of Changes in Beneficial Ownership · Filed 2025-12-01
Stevens Meredith Files Kenvue (KVUE) Form 4 - December 01, 2025
Stevens Meredith traded 4.0K KVUE shares worth $20.3K in this Form 4 filing, reported to the SEC on 2025-12-01.
- Insider
- Stevens Meredith
- Issuer
- Kenvue Inc. KVUE · NYSE
- Filed
- Period
- 2025-12-01
- Accession
- 0001944048-25-000215
- Source
- Official filing on sec.gov ↗
Transactions (2)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Stevens Meredith | 2025-12-01 | Buy | 2.8K | $0.00 | $0.00 | Direct |
| Stevens Meredith | 2025-12-01 | Sell | 1.2K | $17.22 | $20.3K | Direct |
| Net change | +1.6K | −$20.3K | ||||
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Track KVUE insider activity
Get alerted when Kenvue Inc. executives buy or sell their shares.